Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.WomanCare Global (WCG) has acquired Roselle, a combined oral contraceptive (COC) pill composed of 150mg of levonorgestrel and 30mg of ethinylestradiol and Optinor, a progesterone-only emergency contraception pill (ECP) composed of 750mg of levonorgestrel, from ICON.
Subscribe to our email newsletter
ICON, under the partnership with a trusted generic manufacturer has developed both the products following an extensive quality and technical assessment process undertaken by qualified experts in 2005.
With this acquisition, WCG has rights to Roselle and Optinor and a partner in making these branded products available to International Planned Parenthood Federation’s (IPPF) network of Member Associations located in over 170 countries.
ICON general manager David Smith said that the partnership with WCG is a significant step forward in expanding access to generic hormonal contraceptives at competitive prices.
WCG chief operating officer Saundra Pelletier said that the addition of these 2 new products to their portfolio would make a difference to women who deserve access to affordable products.